Description
This procedure involves the amplification and identification of DNA or RNA targets from a previously cultured blood specimen. It specifically detects at least six genetic markers to accurately identify pathogenic organisms and assess their resistance to medications.
—
—
No crosswalks found.
No alternates found.
No codes found here.
We make no claims to ownership of the coding systems referenced on this platform. Codes and descriptions are produced from claims and chargemaster data available through the CMS-9915-F Transparency in Coverage Final Rule and via state or federal datasets. This service is provided solely as a reference to encourage use of these codes in our chargemaster review and automated billing tools, so that healthcare professionals can understand and correctly report these codes in their claims.